Addex Therapeutics Ltd.

ADXN·NASDAQ·$6.75Share Price as of 11/2·$5MMarket Cap as of 11/2

Financials

20-FAnnual report (foreign)05/15/26 20-FAnnual report (foreign)05/15/25 20-FAnnual report (foreign)04/18/24 20-FAnnual report (foreign)03/30/23 20-FAnnual report (foreign)03/10/22

Disclosures

6-KForeign issuer report10/29/26 6-KForeign issuer report10/08/26 6-KForeign issuer report10/02/26 6-KForeign issuer report09/28/26 6-KForeign issuer report09/25/26

Prospectuses and Registrations

424B5Prospectus supplement12/10/25 F-3Shelf registration (foreign)11/19/25 424B3Prospectus04/24/24 POS AMPost-effective amendment04/18/24 424B5Prospectus supplement01/30/24

Proxies

No matching filings.

Ownership

Form 4Insider transaction09/04/26 Form 4Insider transaction09/04/26 Form 4Insider transaction09/04/26 Form 4Insider transaction09/04/26 Form 4Insider transaction09/04/26

Other

NT 20-FLate filing notification (20-F)04/30/26 EFFECTRequest for effectiveness12/05/25 CORRESPCorrespondence with the SEC12/03/25 NT 20-FLate filing notification (20-F)04/30/25 EFFECTRequest for effectiveness04/22/24